Neuroblastoma stage 4S: A multifocal stem-cell disease of the developing neural crest

The Lancet Oncology

Volumn 13, Issue 3, 2012, Pages 229-230

  van Noesel, Max M ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTROPHIN RECEPTOR P75; TRANSCRIPTION FACTOR SOX10;

APOPTOSIS; BONE MARROW METASTASIS; CANCER GENETICS; CANCER STAGING; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MIGRATION; EMBRYO DEVELOPMENT; GENE MUTATION; HIGH RISK PATIENT; HUMAN; LETTER; LIVER METASTASIS; MELANOCYTE; MULTIFOCAL STEM CELL DISEASE; NEURAL CREST; NEURAL CREST DEVELOPMENT; NEUROBLASTOMA; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; SKIN METASTASIS; STEM CELL; TUMOR VOLUME;

ADRENAL GLAND NEOPLASMS; ANIMALS; BONE MARROW NEOPLASMS; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASTIC STEM CELLS; NEURAL CREST; NEUROBLASTOMA; PROGNOSIS; SKIN NEOPLASMS;

EID: 84857484946     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(12)70012-8     Document Type: Letter

References (11)

1. Evans AE, D'Angio GJ, Randolph J A proposed staging for children with neuroblastoma: children's cancer study group A. Cancer 1971, 27:374-378.
2. Brodeur GM, Seeger RC, Barrett A, et al. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 1988, 6:1874-1881.
3. van Noesel MM, Hahlen K, Hakvoort-Cammel FG, Egeler RM Neuroblastoma 4S: a heterogeneous disease with variable risk factors and treatment strategies. Cancer 1997, 80:834-843.
4. Vandesompele J, Speleman F, Van Roy N, et al. Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there?. Med Pediatr Oncol 2001, 36:5-10.
5. Benard J, Raguenez G, Kauffmann A, et al. MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4S. Mol Oncol 2008, 2:261-271.
6. Wong CE, Paratore C, Dours-Zimmermann MT, et al. Neural crest-derived cells with stem cell features can be traced back to multiple lineages in the adult skin. J Cell Biol 2006, 175:1005-1015.
7. Nagoshi N, Shibata S, Kubota Y, et al. Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad. Cell Stem Cell 2008, 2:392-403.
8. Bunone G, Mariotti A, Compagni A, Morandi E, Della Valle G Induction of apoptosis by p75 neurotrophin receptor in human neuroblastoma cells. Oncogene 1997, 14:1463-1470.
9. Iraci N, Diolaiti D, Papa A, et al. A SP1/MIZ1/MYCN repression complex recruits HDAC1 at the TRKA and p75NTR promoters and affects neuroblastoma malignancy by inhibiting the cell response to NGF. Cancer Res 2011, 71:404-412.
10. Hansford LM, McKee AE, Zhang L, et al. Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell. Cancer Res 2007, 67:11234-11243.
11. Dupin E, Calloni GW, Le Douarin NM The cephalic neural crest of amniote vertebrates is composed of a large majority of precursors endowed with neural, melanocytic, chondrogenic and osteogenic potentialities. Cell Cycle 2010, 9:238-249.